Exact Mass: 827.6486134

PC(22:0/P-18:1(11Z))

C48H94NO7P (827.6767543999999)

PC(22:0/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/P-18:1(11Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(22:0/P-18:1(9Z))

C48H94NO7P (827.6767543999999)

PC(22:0/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/P-18:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(22:1(13Z)/P-18:0)

C48H94NO7P (827.6767543999999)

PC(22:1(13Z)/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:1(13Z)/P-18:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(24:1(15Z)/P-16:0)

C48H94NO7P (827.6767543999999)

PC(24:1(15Z)/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:1(15Z)/P-16:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The nervonic acid moiety is derived from fish oils, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PE(18:1(11Z)/24:1(15Z))

C47H90NO8P (827.640371)

PE(18:1(11Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(11Z)/24:1(15Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(18:1(9Z)/24:1(15Z))

C47H90NO8P (827.640371)

PE(18:1(9Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(9Z)/24:1(15Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(18:2(9Z,12Z)/24:0)

C47H90NO8P (827.640371)

PE(18:2(9Z,12Z)/24:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:2(9Z,12Z)/24:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(20:0/22:2(13Z,16Z))

C47H90NO8P (827.640371)

PE(20:0/22:2(13Z,16Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/22:2(13Z,16Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(20:1(11Z)/22:1(13Z))

C47H90NO8P (827.640371)

PE(20:1(11Z)/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/22:1(13Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of erucic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:1(11Z)/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/22:1(13Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of erucic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(20:2(11Z,14Z)/22:0)

C47H90NO8P (827.640371)

PE(20:2(11Z,14Z)/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:2(11Z,14Z)/22:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of behenic acid at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:2(11Z,14Z)/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:2(11Z,14Z)/22:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of behenic acid at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(22:0/20:2(11Z,14Z))

C47H90NO8P (827.640371)

PE(22:0/20:2(11Z,14Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/20:2(11Z,14Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(22:0/20:2(11Z,14Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/20:2(11Z,14Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(22:1(13Z)/20:1(11Z))

C47H90NO8P (827.640371)

PE(22:1(13Z)/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/20:1(11Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(22:2(13Z,16Z)/20:0)

C47H90NO8P (827.640371)

PE(22:2(13Z,16Z)/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:2(13Z,16Z)/20:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The docosadienoic acid moiety is derived from animal fats, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(22:2(13Z,16Z)/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:2(13Z,16Z)/20:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The docosadienoic acid moiety is derived from animal fats, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(24:0/18:2(9Z,12Z))

C47H90NO8P (827.640371)

PE(24:0/18:2(9Z,12Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/18:2(9Z,12Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of linoleic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(24:1(15Z)/18:1(11Z))

C47H90NO8P (827.640371)

PE(24:1(15Z)/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/18:1(11Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(24:1(15Z)/18:1(9Z))

C47H90NO8P (827.640371)

PE(24:1(15Z)/18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/18:1(9Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of oleic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PC(P-16:0/24:1(15Z))

C48H94NO7P (827.6767543999999)

PC(P-16:0/24:1(15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/24:1(15Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of nervonic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(P-18:0/22:1(13Z))

C48H94NO7P (827.6767543999999)

PC(P-18:0/22:1(13Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/22:1(13Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of erucic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(P-18:1(11Z)/22:0)

C48H94NO7P (827.6767543999999)

PC(P-18:1(11Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/22:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of behenic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(P-18:1(9Z)/22:0)

C48H94NO7P (827.6767543999999)

PC(P-18:1(9Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/22:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of behenic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(O-18:2(9Z,12Z)/22:0)

C48H94NO7P (827.6767543999999)

PC(O-18:2(9Z,12Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-18:2(9Z,12Z)/22:0), in particular, consists of one chain of Linoleyl alcohol at the C-1 position and one chain of behenic acid at the C-2 position. The Linoleyl alcohol moiety is derived from seed oils, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-18:2(9Z,12Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:2(9Z,12Z)/22:0), in particular, consists of one chain of Linoleyl alcohol at the C-1 position and one chain of behenic acid at the C-2 position. The Linoleyl alcohol moiety is derived from seed oils, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe2(16:1(9Z)/24:1(15Z))

C47H90NO8P (827.640371)

PE-NMe2(16:1(9Z)/24:1(15Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(16:1(9Z)/24:1(15Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(18:0/22:2(13Z,16Z))

C47H90NO8P (827.640371)

PE-NMe2(18:0/22:2(13Z,16Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:0/22:2(13Z,16Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(18:1(11Z)/22:1(13Z))

C47H90NO8P (827.640371)

PE-NMe2(18:1(11Z)/22:1(13Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(11Z)/22:1(13Z)), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(18:1(9Z)/22:1(13Z))

C47H90NO8P (827.640371)

PE-NMe2(18:1(9Z)/22:1(13Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(9Z)/22:1(13Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(18:2(9Z,12Z)/22:0)

C47H90NO8P (827.640371)

PE-NMe2(18:2(9Z,12Z)/22:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:2(9Z,12Z)/22:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:0/20:2(11Z,14Z))

C47H90NO8P (827.640371)

PE-NMe2(20:0/20:2(11Z,14Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:0/20:2(11Z,14Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:1(11Z)/20:1(11Z))

C47H90NO8P (827.640371)

PE-NMe2(20:1(11Z)/20:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:1(11Z)/20:1(11Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:2(11Z,14Z)/20:0)

C47H90NO8P (827.640371)

PE-NMe2(20:2(11Z,14Z)/20:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:2(11Z,14Z)/20:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:0/18:2(9Z,12Z))

C47H90NO8P (827.640371)

PE-NMe2(22:0/18:2(9Z,12Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:0/18:2(9Z,12Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of linoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:1(13Z)/18:1(11Z))

C47H90NO8P (827.640371)

PE-NMe2(22:1(13Z)/18:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:1(13Z)/18:1(11Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of cis-vaccenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:1(13Z)/18:1(9Z))

C47H90NO8P (827.640371)

PE-NMe2(22:1(13Z)/18:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:1(13Z)/18:1(9Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of oleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:2(13Z,16Z)/18:0)

C47H90NO8P (827.640371)

PE-NMe2(22:2(13Z,16Z)/18:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:2(13Z,16Z)/18:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(24:1(15Z)/16:1(9Z))

C47H90NO8P (827.640371)

PE-NMe2(24:1(15Z)/16:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(24:1(15Z)/16:1(9Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE 42:2

C47H90NO8P (827.640371)

Found in mouse lung; TwoDicalId=758; MgfFile=160901_Lung_normal_Neg_04; MgfId=1584

Lecithin

C48H94NO7P (827.6767543999999)

PE(42:2)

C47H90NO8P (827.640371)

PC(17:0/22:2(13Z,16Z))

C47H90NO8P (827.640371)

PC(17:1(9Z)/22:1(11Z))

C47H90NO8P (827.640371)

PC(17:2(9Z,12Z)/22:0)

C47H90NO8P (827.640371)

PC(18:2(9Z,12Z)/21:0)

C47H90NO8P (827.640371)

PC(19:0/20:2(11Z,14Z))

C47H90NO8P (827.640371)

PC(19:1(9Z)/20:1(11Z))

C47H90NO8P (827.640371)

PC(20:1(11Z)/19:1(9Z))

C47H90NO8P (827.640371)

PC(20:2(11Z,14Z)/19:0)

C47H90NO8P (827.640371)

PC(21:0/18:2(9Z,12Z))

C47H90NO8P (827.640371)

PC(22:0/17:2(9Z,12Z))

C47H90NO8P (827.640371)

PC(22:1(11Z)/17:1(9Z))

C47H90NO8P (827.640371)

PC(22:2(13Z,16Z)/17:0)

C47H90NO8P (827.640371)

PC(O-18:0/22:2(13Z,16Z))

C48H94NO7P (827.6767543999999)

PC(O-20:0/20:2(11Z,14Z))

C48H94NO7P (827.6767543999999)

PC(P-18:0/22:1(11Z))

C48H94NO7P (827.6767543999999)

PC(P-20:0/20:1(11Z))

C48H94NO7P (827.6767543999999)

PE(20:1(11Z)/22:1(11Z))

C47H90NO8P (827.640371)

PE(22:1(11Z)/20:1(11Z))

C47H90NO8P (827.640371)

PC 39:2

C47H90NO8P (827.640371)

PC O-40:2

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] (Z)-tetracos-13-enoate

C47H90NO8P (827.640371)

1-Tetracosanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoethanolamine

C47H90NO8P (827.640371)

[3-icosanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

HexCer 8:1;2O/36:6

C50H85NO8 (827.627485)

HexCer 8:0;2O/36:7

C50H85NO8 (827.627485)

NAGly 26:6/26:4

C54H85NO5 (827.6427399999999)

HexCer 10:1;2O/34:6

C50H85NO8 (827.627485)

HexCer 26:3;2O/18:4

C50H85NO8 (827.627485)

HexCer 22:3;2O/22:4

C50H85NO8 (827.627485)

HexCer 20:2;2O/24:5

C50H85NO8 (827.627485)

HexCer 16:3;2O/28:4

C50H85NO8 (827.627485)

HexCer 24:3;2O/20:4

C50H85NO8 (827.627485)

HexCer 22:1;2O/22:6

C50H85NO8 (827.627485)

HexCer 18:2;2O/26:5

C50H85NO8 (827.627485)

HexCer 20:3;2O/24:4

C50H85NO8 (827.627485)

HexCer 16:0;2O/28:7

C50H85NO8 (827.627485)

HexCer 14:1;2O/30:6

C50H85NO8 (827.627485)

HexCer 16:2;2O/28:5

C50H85NO8 (827.627485)

HexCer 16:1;2O/28:6

C50H85NO8 (827.627485)

HexCer 12:1;2O/32:6

C50H85NO8 (827.627485)

HexCer 18:1;2O/26:6

C50H85NO8 (827.627485)

HexCer 20:1;2O/24:6

C50H85NO8 (827.627485)

HexCer 14:0;2O/30:7

C50H85NO8 (827.627485)

HexCer 12:2;2O/32:5

C50H85NO8 (827.627485)

HexCer 26:2;2O/18:5

C50H85NO8 (827.627485)

HexCer 22:2;2O/22:5

C50H85NO8 (827.627485)

HexCer 18:3;2O/26:4

C50H85NO8 (827.627485)

HexCer 14:3;2O/30:4

C50H85NO8 (827.627485)

HexCer 24:2;2O/20:5

C50H85NO8 (827.627485)

HexCer 14:2;2O/30:5

C50H85NO8 (827.627485)

HexCer 18:0;2O/26:7

C50H85NO8 (827.627485)

HexCer 12:0;2O/32:7

C50H85NO8 (827.627485)

HexCer 10:0;2O/34:7

C50H85NO8 (827.627485)

HexCer 28:3;2O/16:4

C50H85NO8 (827.627485)

[3-dodecoxy-2-[(17Z,20Z)-octacosa-17,20-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

2-[2-[(14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-14,17,20,23,26,29-hexaenoyl]oxy-3-octanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

Lnape 23:0/N-19:2

C47H90NO8P (827.640371)

Lnape 22:2/N-20:0

C47H90NO8P (827.640371)

Lnape 26:2/N-16:0

C47H90NO8P (827.640371)

Lnape 21:0/N-21:2

C47H90NO8P (827.640371)

Lnape 16:1/N-26:1

C47H90NO8P (827.640371)

Lnape 21:1/N-21:1

C47H90NO8P (827.640371)

Lnape 18:1/N-24:1

C47H90NO8P (827.640371)

Lnape 24:1/N-18:1

C47H90NO8P (827.640371)

Lnape 20:0/N-22:2

C47H90NO8P (827.640371)

Lnape 24:0/N-18:2

C47H90NO8P (827.640371)

Lnape 16:0/N-26:2

C47H90NO8P (827.640371)

Lnape 21:2/N-21:0

C47H90NO8P (827.640371)

Lnape 20:1/N-22:1

C47H90NO8P (827.640371)

Lnape 18:2/N-24:0

C47H90NO8P (827.640371)

Lnape 22:0/N-20:2

C47H90NO8P (827.640371)

Lnape 19:2/N-23:0

C47H90NO8P (827.640371)

Lnape 25:0/N-17:2

C47H90NO8P (827.640371)

Lnape 20:2/N-22:0

C47H90NO8P (827.640371)

Lnape 26:0/N-16:2

C47H90NO8P (827.640371)

Lnape 17:2/N-25:0

C47H90NO8P (827.640371)

Lnape 18:0/N-24:2

C47H90NO8P (827.640371)

Lnape 26:1/N-16:1

C47H90NO8P (827.640371)

Lnape 24:2/N-18:0

C47H90NO8P (827.640371)

Lnape 22:1/N-20:1

C47H90NO8P (827.640371)

Lnape 16:2/N-26:0

C47H90NO8P (827.640371)

2-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[3-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-octadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[2-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[3-hexadecanoyloxy-2-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[2-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-3-tetradecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-[(Z)-icos-11-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[3-decanoyloxy-2-[(12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-12,15,18,21,24,27-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-2-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[3-[(Z)-docos-13-enoyl]oxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[2,3-bis[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy]propoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[3-dodecanoyloxy-2-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

2-[3-[(Z)-hexadec-9-enoyl]oxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C50H85NO8 (827.627485)

HexCer 9:0;3O/32:2;(2OH)

C47H89NO10 (827.6486134)

HexCer 12:1;3O/29:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 13:1;3O/28:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 11:0;3O/30:2;(2OH)

C47H89NO10 (827.6486134)

HexCer 13:0;3O/28:2;(2OH)

C47H89NO10 (827.6486134)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-octacos-17-enoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] tetracosanoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-tetracos-13-enoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentacosoxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexacosoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] tricosanoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] henicosanoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (Z)-henicos-11-enoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (Z)-docos-13-enoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptacosoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexacos-15-enoxy]propan-2-yl] (Z)-heptadec-9-enoate

C48H94NO7P (827.6767543999999)

(4E,8E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxypentacosa-4,8-diene-1-sulfonic acid

C51H89NO5S (827.6461104)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (Z)-hexacos-15-enoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetracosoxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C48H94NO7P (827.6767543999999)

2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxypentacosane-1-sulfonic acid

C51H89NO5S (827.6461104)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] docosanoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] pentadecanoate

C48H94NO7P (827.6767543999999)

(E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxypentacos-4-ene-1-sulfonic acid

C51H89NO5S (827.6461104)

(4E,8E,12E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxypentacosa-4,8,12-triene-1-sulfonic acid

C51H89NO5S (827.6461104)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] nonadecanoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] (Z)-nonadec-9-enoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octacos-17-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosoxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] heptadecanoate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] hexacosanoate

C48H94NO7P (827.6767543999999)

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-nonadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(Z)-henicos-11-enoxy]-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(Z)-icos-11-enoxy]-2-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-docosoxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(Z)-docos-13-enoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tetracosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-tricosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-henicosanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-icosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-dodecanoyloxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-henicosoxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-hexadecanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(Z)-hexacos-15-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tetracos-13-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (21Z,24Z)-dotriaconta-21,24-dienoate

C47H90NO8P (827.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (19Z,22Z)-triaconta-19,22-dienoate

C47H90NO8P (827.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C47H90NO8P (827.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-octacos-17-enoate

C47H90NO8P (827.640371)

Cer 16:0;2O/20:6;(3OH)(FA 18:5)

C54H85NO5 (827.6427399999999)

Cer 14:0;2O/20:6;(3OH)(FA 20:5)

C54H85NO5 (827.6427399999999)

Cer 15:0;2O/19:5;(3OH)(FA 20:6)

C54H85NO5 (827.6427399999999)

Cer 14:0;2O/18:5;(3OH)(FA 22:6)

C54H85NO5 (827.6427399999999)

Cer 14:0;2O/20:5;(3OH)(FA 20:6)

C54H85NO5 (827.6427399999999)

Cer 18:0;2O/16:5;(3OH)(FA 20:6)

C54H85NO5 (827.6427399999999)

Cer 16:0;2O/16:5;(3OH)(FA 22:6)

C54H85NO5 (827.6427399999999)

Cer 15:0;2O/20:6;(3OH)(FA 19:5)

C54H85NO5 (827.6427399999999)

Cer 14:0;2O/22:6;(3OH)(FA 18:5)

C54H85NO5 (827.6427399999999)

Cer 18:0;2O/20:6;(3OH)(FA 16:5)

C54H85NO5 (827.6427399999999)

Cer 16:0;2O/18:5;(3OH)(FA 20:6)

C54H85NO5 (827.6427399999999)

Cer 16:0;2O/22:6;(3OH)(FA 16:5)

C54H85NO5 (827.6427399999999)

Lpc 40:2-SN1

C48H94NO7P (827.6767543999999)

4-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(Z)-henicos-11-enoyl]oxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-henicosanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

HexCer 27:2;3O/14:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 21:2;3O/20:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 25:1;3O/16:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 21:1;3O/20:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 20:2;3O/21:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 23:2;3O/18:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 24:2;3O/17:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 22:1;3O/19:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 14:2;3O/27:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 15:2;3O/26:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 16:1;3O/25:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 15:0;3O/26:2;(2OH)

C47H89NO10 (827.6486134)

HexCer 19:2;3O/22:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 23:1;3O/18:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 18:2;3O/23:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 17:2;3O/24:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 25:0;3O/16:2;(2OH)

C47H89NO10 (827.6486134)

HexCer 19:1;3O/22:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 26:1;3O/15:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 25:2;3O/16:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 29:1;3O/12:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 18:1;3O/23:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 17:0;3O/24:2;(2OH)

C47H89NO10 (827.6486134)

HexCer 28:2;3O/13:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 23:0;3O/18:2;(2OH)

C47H89NO10 (827.6486134)

HexCer 27:1;3O/14:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 26:2;3O/15:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 21:0;3O/20:2;(2OH)

C47H89NO10 (827.6486134)

HexCer 17:1;3O/24:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 19:0;3O/22:2;(2OH)

C47H89NO10 (827.6486134)

HexCer 20:1;3O/21:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 14:1;3O/27:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 29:2;3O/12:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 16:2;3O/25:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 28:1;3O/13:1;(2OH)

C47H89NO10 (827.6486134)

HexCer 22:2;3O/19:0;(2OH)

C47H89NO10 (827.6486134)

HexCer 15:1;3O/26:1;(2OH)

C47H89NO10 (827.6486134)

[3-hexadecoxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] heptacosanoate

C48H94NO7P (827.6767543999999)

[2-docosanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-[(Z)-hexacos-15-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[3-[(Z)-hexadec-9-enoxy]-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] pentacosanoate

C48H94NO7P (827.6767543999999)

[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (23Z,26Z)-tetratriaconta-23,26-dienoate

C47H90NO8P (827.640371)

[3-nonanoyloxy-2-[(19Z,22Z)-triaconta-19,22-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] tetracosanoate

C47H90NO8P (827.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C47H90NO8P (827.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-henicos-11-enoyl]oxypropyl] (Z)-henicos-11-enoate

C47H90NO8P (827.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropan-2-yl] (Z)-hexacos-15-enoate

C47H90NO8P (827.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C47H90NO8P (827.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] pentacosanoate

C47H90NO8P (827.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoyl]oxypropan-2-yl] (Z)-docos-13-enoate

C47H90NO8P (827.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] hexacosanoate

C47H90NO8P (827.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] henicosanoate

C47H90NO8P (827.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] docosanoate

C47H90NO8P (827.640371)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] tricosanoate

C47H90NO8P (827.640371)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C47H90NO8P (827.640371)

[2-[(17Z,20Z)-octacosa-17,20-dienoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[2-[(Z)-hexacos-15-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[3-[(Z)-pentadec-9-enoyl]oxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[3-pentadecanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[3-henicosanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[3-docosanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2S)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2R)-3-[(E)-pentadec-9-enoyl]oxy-2-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropan-2-yl] pentacosanoate

C47H90NO8P (827.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-13-enoyl]oxypropan-2-yl] (E)-docos-13-enoate

C47H90NO8P (827.640371)

[(2R)-3-[(E)-icos-1-enoxy]-2-[(E)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

4-[2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxy-3-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-[(E)-pentacos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-[(E)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2S)-3-[(E)-docos-13-enoyl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(10E,12E)-octadeca-10,12-dienoyl]oxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

4-[2-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-docosanoyloxy-3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-icosanoyloxypropyl] (13E,16E)-docosa-13,16-dienoate

C47H90NO8P (827.640371)

4-[3-henicosanoyloxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-2-[(5E,8E)-icosa-5,8-dienoyl]oxy-3-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

4-[3-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-[(E)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-13-enoyl]oxypropyl] (E)-docos-13-enoate

C47H90NO8P (827.640371)

4-[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] (E)-hexacos-5-enoate

C47H90NO8P (827.640371)

4-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-[(E)-heptadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropan-2-yl] tetracosanoate

C47H90NO8P (827.640371)

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] (E)-hexacos-5-enoate

C47H90NO8P (827.640371)

4-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(E)-hexadec-7-enoyl]oxy-3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-7-enoyl]oxypropan-2-yl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

4-[3-heptadecanoyloxy-2-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosanoyloxypropan-2-yl] (13E,16E)-docosa-13,16-dienoate

C47H90NO8P (827.640371)

4-[2-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-2-henicosanoyloxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C47H90NO8P (827.640371)

4-[3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxy-2-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-13-enoyl]oxypropan-2-yl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

4-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropan-2-yl] docosanoate

C47H90NO8P (827.640371)

4-[2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropyl] pentacosanoate

C47H90NO8P (827.640371)

4-[3-[(E)-hexadec-7-enoyl]oxy-2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-11-enoyl]oxypropan-2-yl] (E)-docos-13-enoate

C47H90NO8P (827.640371)

4-[3-[(E)-heptadec-7-enoyl]oxy-2-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-2-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[3-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-2-icosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

4-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(E)-henicos-9-enoyl]oxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropan-2-yl] tetracosanoate

C47H90NO8P (827.640371)

4-[3-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-2-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5E,8E)-icosa-5,8-dienoyl]oxypropan-2-yl] docosanoate

C47H90NO8P (827.640371)

[(2R)-3-henicosanoyloxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxy-3-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-heptadecanoyloxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropan-2-yl] tetracosanoate

C47H90NO8P (827.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-4-enoyl]oxypropan-2-yl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

4-[3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-henicosanoyloxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-hexadecanoyloxy-3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-9-enoyl]oxypropan-2-yl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

[(2R)-2-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[2-[(E)-docos-11-enoyl]oxy-3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-3-henicosanoyloxy-2-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadec-17-enoyloxypropan-2-yl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] tetracosanoate

C47H90NO8P (827.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,8E)-icosa-5,8-dienoyl]oxypropyl] docosanoate

C47H90NO8P (827.640371)

4-[2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-3-[(E)-tricos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-pentacosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-3-henicosanoyloxy-2-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-3-icosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropyl] docosanoate

C47H90NO8P (827.640371)

4-[3-[(E)-henicos-9-enoyl]oxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-2-docosanoyloxy-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-pentacosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-2-henicosanoyloxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-octadec-17-enoyloxypropyl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

[(2R)-2-henicosanoyloxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-icos-11-enoyl]oxypropyl] (E)-docos-13-enoate

C47H90NO8P (827.640371)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropan-2-yl] tetracosanoate

C47H90NO8P (827.640371)

4-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] tetracosanoate

C47H90NO8P (827.640371)

[(2S)-2-[(E)-pentadec-9-enoyl]oxy-3-[(E)-tetracos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] tetracosanoate

C47H90NO8P (827.640371)

4-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(E)-pentacos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-11-enoyl]oxypropan-2-yl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(E)-octadec-11-enoyl]oxy-3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-6-enoyl]oxypropan-2-yl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

[(2R)-2-henicosanoyloxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[3-hexadecanoyloxy-2-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(E)-heptadec-7-enoyl]oxy-3-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-3-[(E)-icos-1-enoxy]-2-[(E)-icos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C48H94NO7P (827.6767543999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] (E)-hexacos-5-enoate

C47H90NO8P (827.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] (E)-hexacos-5-enoate

C47H90NO8P (827.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C47H90NO8P (827.640371)

4-[3-octadecanoyloxy-2-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-3-henicosanoyloxy-2-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] (E)-tetracos-15-enoate

C47H90NO8P (827.640371)

4-[3-[(10E,12E)-octadeca-10,12-dienoyl]oxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] tetracosanoate

C47H90NO8P (827.640371)

[(2S)-3-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

[(2S)-3-docosanoyloxy-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-2-[(E)-tricos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[(2R)-3-[(5E,8E)-icosa-5,8-dienoyl]oxy-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C47H90NO8P (827.640371)

4-[2-octadecanoyloxy-3-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(E)-octadec-11-enoyl]oxy-2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropyl] hexacosanoate

C47H90NO8P (827.640371)

4-[3-[(E)-docos-11-enoyl]oxy-2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-docosanoyloxy-2-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

4-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C51H89NO7 (827.6638684)

2-[[(8E,12E,16E)-3,4-dihydroxy-2-(tetracosanoylamino)octadeca-8,12,16-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C47H92N2O7P+ (827.6641792)

2-[[(8E,12E)-3,4-dihydroxy-2-[[(Z)-tetracos-13-enoyl]amino]octadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C47H92N2O7P+ (827.6641792)

2-[[(E)-3,4-dihydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]octadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C47H92N2O7P+ (827.6641792)

2-[[3,4-dihydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]octadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C47H92N2O7P+ (827.6641792)

PC(O-18:2(9Z,12Z)/22:0)

C48H94NO7P (827.6767543999999)

PE-NMe2(16:1(9Z)/24:1(15Z))

C47H90NO8P (827.640371)

phosphatidylethanolamine 42:2 zwitterion

C47H90NO8P (827.640371)

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 42 carbons in total with 2 double bonds.

phosphatidylcholine O-40:2

C48H94NO7P (827.6767543999999)

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 40 carbons and 2 double bonds.

1-octadecyl-2-[(13Z,16Z)-docosadienoyl]-sn-glycero-3-phosphocholine

C48H94NO7P (827.6767543999999)

A phosphatidylcholine O-40:2 in which the alkyl and acyl groups at positions 1 and 2 are octadecyl and (13Z,16Z)-docosadienoyl respectively.

MePC(38:2)

C47H90NO8P (827.640371)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

MePC(39:2)

C48H94NO7P (827.6767543999999)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(44:7)

C50H85NO8 (827.627485)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

dMePE(40:2)

C47H90NO8P (827.640371)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 37:1;O2

C47H89NO10 (827.6486134)

DGCC 40:6

C50H85NO8 (827.627485)

DGTS 40:6;O

C50H85NO8 (827.627485)

DGTS 41:5

C51H89NO7 (827.6638684)

PC O-14:0/26:2

C48H94NO7P (827.6767543999999)

PC O-14:1/26:1

C48H94NO7P (827.6767543999999)

PC O-16:1/24:1

C48H94NO7P (827.6767543999999)

PC O-16:2/24:0

C48H94NO7P (827.6767543999999)

PC O-18:0/22:2

C48H94NO7P (827.6767543999999)

PC O-18:1/22:1

C48H94NO7P (827.6767543999999)

PC O-18:2/22:0

C48H94NO7P (827.6767543999999)

PC O-20:0/20:2

C48H94NO7P (827.6767543999999)

PC O-20:1/20:1

C48H94NO7P (827.6767543999999)

PC O-20:2/20:0

C48H94NO7P (827.6767543999999)

PC O-22:0/18:2

C48H94NO7P (827.6767543999999)

PC O-22:1/18:1

C48H94NO7P (827.6767543999999)

PC O-22:2/18:0

C48H94NO7P (827.6767543999999)

PC P-14:0/26:1

C48H94NO7P (827.6767543999999)

PC P-14:0/26:1 or PC O-14:1/26:1

C48H94NO7P (827.6767543999999)

PC P-16:0/24:1

C48H94NO7P (827.6767543999999)

PC P-16:0/24:1 or PC O-16:1/24:1

C48H94NO7P (827.6767543999999)

PC P-16:1/24:0

C48H94NO7P (827.6767543999999)

PC P-16:1/24:0 or PC O-16:2/24:0

C48H94NO7P (827.6767543999999)

PC P-18:0/22:1

C48H94NO7P (827.6767543999999)

PC P-18:0/22:1 or PC O-18:1/22:1

C48H94NO7P (827.6767543999999)

PC P-18:1/22:0

C48H94NO7P (827.6767543999999)

PC P-18:1/22:0 or PC O-18:2/22:0

C48H94NO7P (827.6767543999999)

PC P-20:0/20:1

C48H94NO7P (827.6767543999999)

PC P-20:0/20:1 or PC O-20:1/20:1

C48H94NO7P (827.6767543999999)

PC P-20:1/20:0

C48H94NO7P (827.6767543999999)

PC P-20:1/20:0 or PC O-20:2/20:0

C48H94NO7P (827.6767543999999)

PC P-22:0/18:1

C48H94NO7P (827.6767543999999)

PC P-22:0/18:1 or PC O-22:1/18:1

C48H94NO7P (827.6767543999999)

PC P-22:1/18:0

C48H94NO7P (827.6767543999999)

PC P-22:1/18:0 or PC O-22:2/18:0

C48H94NO7P (827.6767543999999)

PC 13:0_26:2

C47H90NO8P (827.640371)

PC 15:1_24:1

C47H90NO8P (827.640371)

PC 17:0_22:2

C47H90NO8P (827.640371)

PC 17:1_22:1

C47H90NO8P (827.640371)

PC 17:2_22:0

C47H90NO8P (827.640371)

PC 18:1_21:1

C47H90NO8P (827.640371)

PC 18:2_21:0

C47H90NO8P (827.640371)

PC 19:0_20:2

C47H90NO8P (827.640371)

LNAPE 42:2

C47H90NO8P (827.640371)

PE 16:0_26:2

C47H90NO8P (827.640371)

PE 16:1_26:1

C47H90NO8P (827.640371)

PE 17:2_25:0

C47H90NO8P (827.640371)

PE 18:1_24:1

C47H90NO8P (827.640371)

PE 18:1/24:1

C47H90NO8P (827.640371)

PE 18:2_24:0

C47H90NO8P (827.640371)

PE 20:0_22:2

C47H90NO8P (827.640371)

PE 20:1_22:1

C47H90NO8P (827.640371)

PE 20:2_22:0

C47H90NO8P (827.640371)

GalCer 22:1;O2/22:6

C50H85NO8 (827.627485)

GalCer 22:2;O2/22:5

C50H85NO8 (827.627485)

GalCer 44:7;O2

C50H85NO8 (827.627485)

GlcCer 22:1;O2/22:6

C50H85NO8 (827.627485)

GlcCer 22:2;O2/22:5

C50H85NO8 (827.627485)

GlcCer 44:7;O2

C50H85NO8 (827.627485)

HexCer 22:1;O2/22:6

C50H85NO8 (827.627485)

HexCer 22:2;O2/22:5

C50H85NO8 (827.627485)

HexCer 44:7;O2

C50H85NO8 (827.627485)